Osteoporosis in hepatitis B patients receiving tenofovir disoproxil fumarate: does fibroblast growth factor 23 play a role?
Article in Journal of Hepatology (May 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Comparison of renal safety and bone mineral density of tenofovir and entecavir in patients with chronic hepatitis B: a systematic review and meta-analysis
Article in International Journal of Infectious Diseases (September 2022)
Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort study
Article in Hepatology International (June 2022)